Cigall Kadoch, Professor of Dana-Farber Cancer Institute and Scientific Founder of Foghorn Therapeutics, shared a post on X about a paper she co-authored with colleagues published in Science:
“A New Year, a new paper out on Jan 1 in Science Magazine! Congratulations to Sid Jain and all our co-authors and collaborators! This study answers a longstanding question in our field regarding recruitment of chromatin regulatory machinery and provides a powerful new framework for development of precision medicines in cancer and beyond!”
Title: A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
Authors: Siddhant U. Jain, Kaylyn E. Williamson, Alexander W. Ying, Aasha M. Turner, Ruidong Jerry Jiang, Shaunak Raval, Kevin So, Maxwell J. Allison, Akshay Sankar, Daniel D. Sáme Guerra, Yutong Lin, Zhe Jiang, Nazar Mashtalir, Henry W. Rohrs, Cheryl F. Lichti, Tom W. Muir, Malvina Papanastasiou, Joao A. Paulo, Steven P. Gygi, Michael L. Gross, and Cigall Kadoch.
You can read the Full Article in Science.
More posts featuring Cigall Kadoch.